Claim early access to Google Ads AI agent
Read More
Stop Wasting Ad Dollars on Junk Leads — Fix It with QLA
Read More

Case Study How GrowthSpree Helped Zelthy Spark Interest Among Patient-Centric Roles in Pharma & Biotech via ABM

Zelthy is a health-tech platform that simplifies clinical research and patient access workflows. It offers customized modules for clinical trials, patient management, and healthcare operations. Zelthy enables seamless digital transformation for pharmaceutical and biotech organizations.
Founded: 2017
Headquaters: Seattle, Washington
Size: 11-50 employees

Objective:

Run an Account-Based Marketing (ABM) campaign to drive interest and schedule meetings with relevant decision-makers across patient services, access, and support functions in pharmaceutical and biotechnology companies.

Challenges:

Before partnering with GrowthSpree, Zelthy faced:

  • Difficulty reaching patient service and access teams via traditional channels
  • Limited engagement from cold outreach
  • Low visibility among decentralized roles within large pharma companies

Implementation:

Strategic Multi-Channel Outreach:

GrowthSpree implemented an ABM campaign using both LinkedIn (Dripify) and Email (Lemlist) to engage multiple stakeholders across touchpoints.

Channel-Specific Execution:

  • LinkedIn Dripify:
    • Personalized connection requests targeting patient service, support, and supply chain roles
    • Follow-up nurture messages to gauge interest and set up conversations
  • Email via Lemlist:
    • Custom-built sequences segmented by geography (India and US)
    • Subject lines and copy optimized for high open and click-through rates
    • Emails dynamically personalized based on job function and company size

Precision Targeting:

  • Focused on companies with 201–10,000+ employees
  • Target personas: Patient Service, Access, Support, and Supply Chain Managers
  • Prioritized the pharmaceutical (71.4%) and biotech (14.3%) sectors

Results Summary:

Overall Outreach:

  • Total Companies Contacted: 369
  • Total Unique Prospects: 1,087
  • Interested Leads: 21
  • Replies Received: 74

LinkedIn (Dripify):

Metric Total India USA
Connection Requests Sent 832 157 675
Acceptances 199 (24%) 44 (28%) 155 (23%)
Replies 60 20 (13%) 40 (6%)
Interested Leads 18 2 16

Email (Lemlist):

Metric Total India USA
Emails Sent 334 136 198
Open Rate 57.2% 66.9% 50.5%
Click-Through Rate 23.9% 39.7% 13.1%
Replied 14 5 9
Interested Leads 3 2 1

Interested Replies Breakdown:

Role % of Interest
Patient Service 42.8%
Patient Access 23.8%
Supply Chain 19.04%
Patient Support 14.2%

Company Size % of Interest
201–10,000 employees 71.4%
10,000+ employees 23.8%

Industry % of Interest
Pharmaceutical 71.4%
Biotechnology Research 14.3%

Interested Replies Breakdown

Based on Job Title:

Based in Industry:

The Interested Prospects are all from

Job Title Number of Interested
Patient Service 9 (42.8%)
Patient Access 5 (23.8%)
Patient Support 3 (14.2%)
Supply Chain 4 (19.04%)


Employee Size:

  • 201-10,000 (71.4%)
  • 10,000 + (23.8%)
  • The majority of interested prospects are from the pharmaceutical industry (71.4%) followed by Biotechnology Research (14.3%).

Continuous Improvement & Recommendations:

  • Next Steps Needed: 22 replies remain uncategorized; clarifying these will help prioritize nurture efforts.
  • Recommendation: Implement structured lead tracking and feedback loops with the Zelthy team to align on lead quality and readiness.

Future Outlook: With strong interest from patient-facing teams, GrowthSpree recommends deeper segmentation (e.g., Trial Ops, Reimbursement Teams) for future waves.

Let us make your growth our obsession.

A quick 30-minute conversation, no strings attached.

What to Expect

Your Free Audit Journey

2
days
📞
15-Min Discovery Call No prep needed

Share your challenges, goals & current setup

🔒
Secure Access Setup 100% secure

NDA signed, read-only access granted

🤖
AI + Expert Analysis AI-powered

Deep-dive into your campaigns & data

📊
Custom Audit Report Yours to keep

Actionable fixes with 90-day roadmap